ELENI PARDALI

Ms. ELENI PARDALI

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Metabolism Open
Verified
Journal Article
Open access
EPELENI PARDALI
ELENI PARDALI
AGArriana Gkouvi
Arriana Gkouvi
KGKalliopi K. Gkouskou
Kalliopi K. Gkouskou
AMAnastasios C. Manolakis
Anastasios C. Manolakis
CTChristina Tsigalou
Christina Tsigalou
MGMaria G Grammatikopoulou
Maria G Grammatikopoulou
The autoimmune protocol diet (AIP) is a personalized elimination diet that aims to determine and exclude the foods that might trigger immune responses, leading to inflammation and symptomatology associated with autoimmune diseases. Focusing on gut health and the importance of the gut microbiome in immune regulation and overall well-being, the AIP starts by eliminating foods that might create negative effects on the patients and continues by developing a personalized and tailored diet plan for them. This comprehensive approach aims to mitigate symptoms and improve quality of life of individuals with autoimmune conditions. This review presents and critically appraises current knowledge on the AIP protocol, highlight any oversights, and discuss findings from relevant clinical trials.

26 April 2025 in Diseases
Verified
Journal Article
Open access
PDF file
EPELENI PARDALI
ELENI PARDALI
MKMarkos Klonizakis
Markos Klonizakis
Dimitrios G. GoulisDimitrios G. Goulis
Dimitrios G. Goulis
Sousana PapadopoulouSousana Papadopoulou
Sousana Papadopoulou
CCChris Cholevas
Chris Cholevas
MGMaria G Grammatikopoulou
Maria G Grammatikopoulou
Sarcopenia is characterized by a loss of muscle mass and function, with significant implications for the physical performance of the affected people. Although commonly associated with aging, disease-related sarcopenia is of great clinical importance, particularly as it impacts disease progression and outcomes. Individuals with rheumatic diseases (RDs), including rheumatoid arthritis, systemic sclerosis, spondyloarthritides, systemic lupus erythematosus, fibromyalgia, myositis, or vasculitis, exhibit a high prevalence of sarcopenia, which exacerbates their clinical symptoms and contributes to poorer disease outcomes. Chronic inflammation influences muscle tissue degradation, causing a decline in physical performance. Apart from the apparent clinical manifestations, patients with RDs also use pharmacological treatments that negatively impact muscle mass further, increasing the risk of sarcopenia. Nutrition (diet and dietary supplements) and exercise interventions have been recommended as protective measures for sarcopenia as they may mitigate its adverse events. The present narrative review seeks to explore the methods used to assess sarcopenia in patients with RDs, its prevalence among them, and the challenges faced by the affected individuals, while critically assessing the appropriateness and limitations of current sarcopenia assessment tools in the context of RDs.

1 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
EPELENI PARDALI
ELENI PARDALI
AGArriana Gkouvi
Arriana Gkouvi
MGMaria G Grammatikopoulou
Maria G Grammatikopoulou
AMAlexandros Mitropoulos
Alexandros Mitropoulos
CCChris Cholevas
Chris Cholevas
MKMarkos Klonizakis
Markos Klonizakis
The gastrointestinal (GI) tract is seriously affected by systemic sclerosis (SSc), due to fibrosis and persistent inflammation. Patients with GI involvement frequently exhibit poor nutritional status, which affects disease burden and quality of life. The aim of the present review was to discuss all nutritional issues in SSc and serve as a primer for the nutritional assessment of patients with scleroderma. Patients with SSc suffer from GI impairments that affect the oral cavity, esophagus, stomach, and small and large intestines. Symptomatology includes microstomia, xerostomia, dysphagia, reflux, esophageal dysmotility, small intestinal bacterial overgrowth (SIBO), and fecal incontinence, among others, which may contribute to inadequate food intake. As a result, patients often suffer from malnutrition, sarcopenia, and frailty, while presenting with micronutrient deficiencies that impact disease outcomes and worsen their condition. This aggravated nutritional status is related to greater disease severity, organ involvement, reduced physical function, and increased length of hospitalization and mortality. GI involvement is well-documented within the SSc population, yet routine nutritional assessments are lacking in the hospital setting. Currently, there is a lack of specific recommendations from scientific societies regarding the nutritional care of patients with SSc. Given the high risk of nutritional impairments in this population, systematic assessments should be undertaken, and novel tools tailored to their unique needs should be developed and implemented.

28 February 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
EPELENI PARDALI
ELENI PARDALI
KKKaterina Maria Kontouli
Katerina Maria Kontouli
AGArriana Gkouvi
Arriana Gkouvi
ITIrene A. Tsakmaki
Irene A. Tsakmaki
EPEleni Patrikiou
Eleni Patrikiou
MGMaria G Grammatikopoulou
Maria G Grammatikopoulou
Sarcopenia is characterized by loss of muscle mass and reduced muscle function, presenting various adverse events, especially when inflammation is present. The present study aimed to determine the prevalence of sarcopenia and sarcopenic obesity among patients with rheumatic and musculoskeletal diseases (RMDs) and identify the risk for sarcopenia using two screening tools the Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) and the Mini Sarcopenia Risk Assessment (MSRA). In this single-center cross-sectional study, 220 consecutive patients visiting the Department of Rheumatology and Clinical Immunology at the University General Hospital of Larissa were interviewed. The EWGSOP criteria were used for the diagnosis of sarcopenia, while sensitivity, specificity, positive predictive values, number needed to screen, and positive and negative likelihood ratios were used to validate the diagnostic validity of the SARC-F and the MSRA. Univariate and multivariate logistic regression analyses were also applied to model the relationship between sarcopenia and other variables. In the total sample, 15.9% of patients were diagnosed with sarcopenia and one patient with sarcopenic obesity. The SARC-F (sensitivity 22.2%, specificity 75.6%), the 5-item (sensitivity 88.9%, specificity 18.9%), and the 7-item MSRA (sensitivity 91.7%, specificity 9.2%) presented poor clinical performance when used for screening alone. Univariate logistic regression analyses showed that underweight status, systemic sclerosis and appetite loss are strong contributors to sarcopenia diagnosis. Sarcopenia is prevalent among RMDs, and screening is essential within RMD clinics. None of the screening tools (SARC-F and MSRA) can stand alone in assessing sarcopenia in patients with RMDs. More research is required to understand sarcopenia in RMDs and validate the wide-using screening tools.

24 June 2025 in Metabolism Open
Verified
Journal Article
Open access
EPELENI PARDALI
ELENI PARDALI
CCChristos Cholevas
Christos Cholevas
OAOdysseas Androutsos
Odysseas Androutsos
CTChristina Tsigalou
Christina Tsigalou
DPDimitrios Poulimeneas
Dimitrios Poulimeneas
MGMaria G Grammatikopoulou
Maria G Grammatikopoulou
Obesity is characterized by the expansion of adipose tissue, contributing to systemic low-grade inflammation, insulin resistance, and widespread disruption of metabolic pathways. These pathophysiological changes are strongly linked to the development of several chronic conditions, including metabolic syndrome, type 2 diabetes, cardiovascular disease, and certain forms of cancer. Metabolomics have emerged as a powerful analytical approach for elucidating obesity-related metabolic disturbances at both the cellular and systemic levels, enabling the identification of specific metabolic signatures associated with disease risk and progression.

12 August 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
EPELENI PARDALI
ELENI PARDALI
KKKaterina Maria Kontouli
Katerina Maria Kontouli
AMAnastasios Manolakis
Anastasios Manolakis
Paraskevi DetopoulouParaskevi Detopoulou
Paraskevi Detopoulou
KAkonstantinos argyriou
konstantinos argyriou
MGMaria G Grammatikopoulou
Maria G Grammatikopoulou
Symptoms related to difficulty in swallowing and bolus transfer from the oral towards the gastric cavity have been collectively termed “dysphagia”. The etiology, gravity and complications of dysphagia warrant a rigorous, often multidisciplinary diagnostic evaluation and individualized management. The present study aimed to evaluate the prevalence of dysphagia among patients with rheumatic and musculoskeletal diseases (RMDs) and identify associated risk factors. This cross-sectional study included 340 consecutive patients diagnosed with RMDs from the Department of Rheumatology and Clinical Immunology situated at the Larissa University General Hospital. Dysphagia was assessed using the Eating Assessment Tool-10 (EAT-10). Univariate and multivariate analyses were performed to explore the associations between dysphagia, specific rheumatic diagnoses, and other contributing clinical and demographic factors. Based on the EAT-10, dysphagia was identified in 35% of the patients, with the most commonly reported issues being difficulty in swallowing solid foods and the sensation of food sticking in the throat. Patients with systemic sclerosis, primary Sjögren’s syndrome, and rheumatoid arthritis were significantly more likely to develop swallowing difficulties. Furthermore, low serum albumin levels, increasing age, and the presence of gastroesophageal reflux were identified as independent predictors of dysphagia. Both overweight/obesity and a diagnosis of axial spondyloarthritis were negatively associated with dysphagia. Age and years since diagnosis were positively correlated with an EAT-10 score ≥ 3, while body mass index and body fat percentage showed negative correlations. Swallowing dysfunction is prevalent among patients with RMDs, particularly in those with specific rheumatic diagnoses. Given its impact on nutritional status and overall quality of life, routine dysphagia screening in clinical settings is essential for the timely identification and management of the condition.